# The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023, Regulation 4: Amendment of regulation 2 in relation to England, Scotland and Wales (interpretation)


In regulation 2(1), insert at the appropriate place—
““statistical review” means a review of the statistical sections of the written notice which a manufacturer or their UK responsible person submits to the Secretary of State pursuant to regulation 16(1) or 29(1) in respect of an intended clinical investigation of a relevant device;”.

---
Source: https://www.legislation.gov.uk/uksi/2023/377/regulation/4 (the official version)
Page: https://openlegislation.uk/medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2023/regulation-4
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

